415capital.com ↗Activity from announced rounds
415 Capital is a specialist venture capital firm investing in medical technology companies and supporting clinical development and commercialization.
415 Capital backs medical innovation with capital, operating expertise and market access. Its portfolio spans areas such as cardiovascular devices, medical robotics, imaging and neuromodulation. The firm’s website distinguishes its 415 Capital fund families from CardioVentures.
The RoundOS financing records include Endovascular Engineering, which develops clot-removal technology, and ReEmerge, which is developing deep-brain stimulation for cognitive deficits following traumatic brain injury. These records are examples of the firm’s medical-device activity, rather than a complete account of its investments or an allocation to a particular fund.
ReEmerge is developing Cognitive Network Restoration Therapy (CNRT) for people with chronic cognitive impairment after brain injury. The treatment targets underactive but viable neural circuits in the central thalamus to restore function across disrupted brain networks; the company is advancing this restorative approach through clinical development.
Develops thrombectomy systems for venous thromboembolism treatment